drugset / Trial / NCT01263197

A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol

NCT01263197

Phase 1 Completed 48 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of LY2216684 on heart rate of participants receiving Albuterol and Propranolol. Information about any side effects that may occur will also be collected.

Timeline

Start
2010-12
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 40 mg Oral
Subject Salbutamol Unknown 2 mg Oral
Subject edivoxetine Small molecule 18 mg Oral